Earlier this month the EU released the European Union Artificial Intelligence Act (The Act). #AAIHmembers Paul Howard, PhD, Senior Director of Amicus Therapeutics, Elaine H., Executive Director of the The Alliance for Artificial Intelligence in Healthcare (AAIH), Mustaqhusain Kazi Global Head of Informatics Strategy and Digital Innovation at Roche, Rafael Rosengarten Co-Founder and CEO of Genialis and James Zanewicz, JD, LLM, RTTP, Chief Business Officer at Tulane University School of Medicine, authored a response of behalf of #AAIH to the provisional agreement. This article provides valuable insights into several key aspects: the presence of bias in healthcare AI, the existing solutions addressed by the General Data Protection Regulation (GDPR), the dedication to ethically implementing AI, and the crucial role of human oversight in enhancing AI literacy. #aiinhealthcare #AI #regulation #GDPR #EU #theAct Read more in the full article here
The Alliance for Artificial Intelligence in Healthcare (AAIH)
医院和医疗保健
Baltimore,Maryland 9,747 位关注者
A global advocacy organization to enable the advancement and use of Artificial Intelligence in healthcare.
关于我们
AAIH is a global advocacy organization whose intent is to enable advancement and use of artificial intelligence in healthcare. AAIH believes that patients’ lives will be improved through investment, innovation, and the thoughtful and responsible application of AI in the discovery and development of new therapies. AAIH and its member companies and organizations are applying state‐of‐the‐art approaches and investing in advanced integrated programs (or solutions) to address society’s need for new, more effective, and accessible healthcare. The AAIH is a coalition of technology developers, pharmaceutical companies, and research organizations who have expressed the common goal of realizing the potential for AI in healthcare to significantly improve quality of care, but who also recognize that difficult questions must be considered. We are acting as a forum for these key conversations and providing a unified voice of the industry in established responsible, ethical, and reasonable standards for the development and implementation of AI in healthcare. AAIH Mandate and Goals -Develop appropriate regulations and industry guidance -Seek engagement with appropriate stakeholders -Interface with Government & NGO’s on growth of AI in healthcare industry -Stimulate data sharing and open access to key findings -Set a model and testing approach for quality control and use of standards -Establish accreditation authority and/or affiliation with academic organizations -Educate general populace, industry stakeholders, and government on value of AI and Machine Learning -Prioritize and tailor forums for regulators, payors, providers, and other end‐users as well as patients, the public, and media -Produce informative and reliable industry reports
- 网站
-
https://www.theaaih.org
The Alliance for Artificial Intelligence in Healthcare (AAIH)的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 2-10 人
- 总部
- Baltimore,Maryland
- 类型
- 非营利机构
- 创立
- 2018
- 领域
- biotechnology、pharmaceuticals、data science、technology、artificial intelligence、research、therapeutics、machine learning、precision medicine、drug discovery和ai in healthcare
地点
-
主要
1340 Smith Ave
US,Maryland,Baltimore,21209
The Alliance for Artificial Intelligence in Healthcare (AAIH)员工
-
Ed Addison
Thought leader in start-ups, AI drug discovery, generative AI, health-tech. Reimagining venture capital. Inspirational professor and public speaker.…
-
James Zanewicz, JD, LLM, RTTP
Creativity, Connectivity & Communication in Biotech, AI & Healthcare | Moderator + Keynote Speaker + Impact & Equity Driven Partner
-
Stacie Calad-Thomson
AI in Healthcare and Life Sciences @NVIDIA | Partnering, Strategy, and Execution
-
Andrea Vuturo
Integrated Marketing & External Communications Strategist
动态
-
The Alliance for Artificial Intelligence in Healthcare (AAIH) #MemberMonday feature this week is ZS! ZS is a management consulting and technology firm focused on transforming global healthcare and beyond, partnering with companies to improve life and how we live it. ZS transforms ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 13,000 employees in over 35 offices worldwide. To learn more about ZS, visit https://www.zs.com/
-
Check out this newsletter from our newest AAIH member DeciBio! They are highlighting some of the latest work in the AI space. Subscribe to keep up with the latest information!
We are excited to launch our monthly AI / ML newsletter today! Our aim is to cover the key news that is happening in the AI space across Drug R&D, Diagnostics, and Healthcare (i.e., the broader ecosystem). Our inaugural newsletter for September covers several key developments. Drug R&D:?Superluminal Medicines Inc. raised?$120M?to advance GPCR-targeted therapies, while Eli Lilly and Company formed a?$409M partnership?with Genetic Leap to tackle RNA targets. Merck Group’s new?$592M?deal with Evaxion Biotech A/S focuses on AI-designed vaccines, and Genesis Therapeutics partnered with Gilead Sciences for?$35M. Diagnostics:?Subtle Medical received NIH funding to enhance its AI-powered MRI tech. IMIDEX and Orbit Genomics teamed up to boost lung cancer detection. Dandelion Health's study shows GLP-1 meds could reduce cardiovascular risk for?44M?patients. Healthcare:?Palantir Technologies and Nebraska Medicine improved patient care, boosting Discharge Lounge usage by?2000%. Roche added?20+ AI algorithms?to its digital pathology platform, and Stryker’s acquisition of care.ai bolsters its smart hospital solutions. Check out the newsletter to learn more about these updates in AI / ML: https://lnkd.in/gyJHi-Gz Subscribe here to get the next newsletter delivered straight to your inbox: https://lnkd.in/gKQn7_zp These headlines were curated by Luka Jelcic, Merouane Ounadjela, Eliza French, Katie Schneider, Graham F., and Rebecca Bair. #AI #MachineLearning #PrecisionMedicineNews
AI / Machine Learning | September Round-Up
DeciBio,发布于领英
-
So many great discussions around AI drug discovery and development were had during our Annual Member Meeting! Exciting things to come as we begin to think and dive deeper into this concept!
The Alliance for Artificial Intelligence in Healthcare (AAIH) annual meeting exceeded expectations. Very high level of speakers from top companies and with Genentech as host we got to see several big pharma companies discussing their strategy in AI drug discovery and development.? I really enjoyed the talk by Amazon Web Services (AWS) presenting their vision for the drug discovery to drug development platform. It is great to see hyperscalers starting to think deeper about what tools do customers want and customers want experimentally-validated tools. Ashley Magargee Mustaqhusain Kazi Daniel Kraft, MD Dan Sheeran (he/him) Stacie Calad-Thomson Shah Nawaz Aliza Apple Lili P. #AAIH #HealthcareAI #AIInHealthcare #InnovationInHealthcare
-
Are you planning to attend BIO on the BAYOU this year?? This 2024 program – which will be held in person in New Orleans, Louisiana – will continue to evolve as it features expert-led panels, private meeting capabilities powered by partneringONE, networking opportunities, and most importantly business-style scientific presentations straight from researchers at leading Gulf South universities including: Tulane University, Auburn University, LSU Health New Orleans, The University of Mississippi, Xavier University of Louisiana, Jackson State University, LSU Health Shreveport, The University of Kentucky, The University of Louisville, Mississippi State, Pennington Biomedical Research Center, The Puerto Rico Science, Technology & Research Trust. the University of Southern Mississippi and the University of Tennessee. Make your travel plans and get ready to join us in New Orleans! #AAIH #BIOontheBAYOU #BIOontheBAYOU2024
-
Join us for the highly anticipated RegTech Africa Digital Healthcare Conference 2024, happening virtually on November 28th - 29th, 2024, from 8:00 AM WAT! The Alliance for Artificial Intelligence in Healthcare (AAIH) is proud to be an Ecosystem Partner for the 2024 Regtech Africa Digital Health Conference. This year's theme centers around innovating healthcare through technology and regulatory transformation across Africa. Expect engaging discussions, expert panels, and thought-provoking insights from leading voices in the healthcare and tech industries. Don’t miss out on this unique opportunity to be part of the movement shaping the future of digital health! Secure your spot now at www.regtechafricadhc.com #RegTechAfrica #DigitalHealthcare #Innovation #HealthTech #Africa
-
After The Alliance for Artificial Intelligence in Healthcare (AAIH) Annual Member Meeting, we want to continue to focus on some key takeaways from our members and attendees! Bob Silverman, Chief Business Officer of Turbine, provided some of his key takeaways and thoughts from the meeting below! - Thrilled about the vast applications of our work, spanning from groundbreaking IP in drug discovery to enhancing operational efficiency throughout the pharmaceutical value chain, including research, discovery, manufacturing, and commercialization. Excited to see the impact this will have across the industry! The AAIH playbook fulfills a huge need for frame working, and will be a great collaborative effort. - In several presentations and lightning talks, the concept of "where the puck is going to be" rather than "where it is right now" emerged prominently. Autonomous agents were a key topic of discussion, highlighting their future potential in our industry. Excited to explore these innovations further! - Data as a differentiator was a common theme and everyone seems to understand quality is more critical than quantity.?However if data is an asset and competitive differentiator, then data will remain very siloed and unshared.?The concept of what is pre-competitive is arguably shrinking? Is that good? What were your key takeaways from the AAIH Annual Member meeting? Weigh in below! #AAIH #AAIHAnnualMemberMeeting #aiinhealthcare
-
The Alliance for Artificial Intelligence in Healthcare (AAIH) #MemberMonday feature this week is Intelligencia AI! Intelligencia AI? leads the way in leveraging proprietary data, biomedical expertise and artificial intelligence (AI) with its patented technology to address significant challenges in the pharmaceutical industry. These challenges include lengthy drug development timelines, excessive costs, and unsustainable return on investment (ROI). Its suite of AI-powered solutions delivers actionable insights crucial in mitigating risks and enhancing decision-making associated with drug development by providing an accurate, unbiased assessment of a drug's probability of success. Founded in 2017, Intelligencia AI is headquartered in New York, NY, with offices in San Francisco, CA, and Athens, Greece, and employs 110 individuals globally. To learn more about Intelligencia AI, visit https://lnkd.in/eVesQ6BD Stay tuned each Monday as we continue to feature our awesome members, both current and new! #AAIH #AAIHmember #artificialintelligence #aiinhealthcare
-
Today we present a special AAIH #StudentSpotlight featuring Abraham Obianke, a registered student member of The Alliance for Artificial Intelligence in Healthcare (AAIH) who has recently concluded his Fetal Health project. Abraham kindly shared this project with us, and we want to share with you; keep reading to learn more! Project: Fetal Health Risk Detection using Machine Learning. Problem Statement:?According to the UNICEF, the neonatal period is the most vulnerable time for a child. Globally, 2.3 million children died in the first month of life in 2022 – approximately 6,300 neonatal deaths every day. Data Source: I retrieved relevant fetal health data from University of California, UC Irvine, dataset archive with over 2126 fetal Cardiotocograms (CTGs) consisting of measurements of fetal heart rate (FHR) and uterine contraction (UC) features classified and labelled by expert Obstetricians. My Data-Driven Solution: I developed a patient triage system that analyzes data from Cardiotogram to detect potential fetal health risks, empowering healthcare professionals and mothers with the knowledge needed to seek timely medical interventions. Project Highlights: 1. Model achieved an accuracy of >90% using KNN machine learning algorithm. 2. Model built on robust dataset classified and labelled by expert Obstetricians to ensure reliable and actionable prediction. 3. Model operationalized with a user friendly flask web application. Why my solution matters: This preventive Machine Learning project in healthcare reflects my dedication to working towards the attainment of 2030 United Nations Sustainable Development Goals, SDGs goal 3 of ending all preventable deaths under five years of age using machine learning techniques and a Data-Driven approach. If you want to read more on Abraham's Fetal Health project, the link to his GitHub repository is included in the comments below!
-
Highlight from last week's AAIH Meeting. AWS?Dan Sheeran (he/him)?gave a great talk on Generative AI in healthcare and life sciences. If you couldn't make it, check out the post below!
A very insightful and practical lecture by Dan Sheeran (he/him) of Amazon Web Services (AWS) at the The Alliance for Artificial Intelligence in Healthcare (AAIH) annual meeting. This is the counterpart of Elena Bonfiglioli at Microsoft. Both companies are competing for the leadership role in healthcare. Do you know what are the most common use cases of generative ai in healthcare? Here you go - you are up for a surprise. And the annual meeting was a blast. I was very impressed by the talk of Ashley Magargee , CEO of Genentech and others. Great job Mustaqhusain Kazi and the #theaaih team! #AI #LifeSciences #drugdiscovery